The Go-Anywhere/Do-Anything Way to Learn & Earn CME & SA
Earn CME & Self-Assessment Credits
- Psychiatry Audio Library: Gain access to over 100 hours of articles with 42 hours added annually.
- In-depth Psychiatry Audio Reviews: Systematic and practical guidance across a wide range of psychiatric disorders and treatment modalities. Always comprehensive and practical reviews.
- CMEtoGO with SA credits: Each year earn up to 42 AMA PRA Category 1 CME Credits™ including 8 ABPN-Approved SA Credits
- CMEtoGO without SA credits: Each year earn up to 34 AMA PRA Category 1 CME Credits™
Backed by the Freedom Guarantee
Cancel anytime, and we will refund the remainder of your subscription
EARN CME & SA CREDITS ON THE GO
Save time with CMEtoGO: Listen and learn while engaging in other activities: do chores, jog, take a leisurely walk, workout at the gym, or drive! CMEtoGO is an effective and easy way to learn that saves you dozens of hours every year! Plus, every annual subscription of CMEtoGO provides 42 AMA PRA Category 1 Credits, including 8 ABPN-Approved SA Credits.
EXTENSIVE AND GROWING AUDIO LIBRARY
We start out 2025 with 100+ hours of audio articles on a wide array of topics plus we’re adding an additional 40+ hours of content in 2025 and each following year. As a CMEtoGO subscriber, you let us know what topic you’d like us to cover, and we’ll get our team of writers on it!
PRACTICAL & RELEVANT LEARNING
Since you can access audio articles on a wide range of psychiatric disorders and treatment, you can tailor your learning to what’s most relevant to you. For example, if you see a patient with, for example, somatic symptom disorder, you can listen to a CMEtoGO presentation on this disorder later that day and be ready to better manage the patient at their next visit.
FREEDOM GUARANTEE
Your investment in CMEtoGO is safe. If it’s not for you, simply cancel and we’ll refund the remainder of your subscription. No hard feelings.
Course Topics by Category
Neurodevelopmental Disorders |
Attention-Deficit Hyperactivity Disorder – Jack Krasuski, MD |
Specific Learning Disorder – Jack Krasuski, MD |
Psychotic Disorders |
Delusional Disorder – Jack Krasuski, MD |
Brief Psychotic Disorder – Daniel R. Hanson, MD |
Schizophrenia – Joseph McEvoy, MD |
Treatment-Resistant Schizophrenia – Sumit Kumar Gupta, MD |
Schizoaffective Disorder – Jack Krasuski, MD |
Postpartum Psychosis – Jennifer L. Payne, MD |
Catatonia – Daniel R. Hanson, MD |
Xanomeline and Trospium for the Treatment of Schizophrenia – Shaun Kink, MD |
Bipolar and Related Disorders |
Bipolar I Disorder – Catherine Deprose, PhD |
Bipolar II Disorder – Adrian Preda, MD |
Treatment-Resistant Acute Mania – Jack Krasuski, MD |
Cyclothymic Disorder- Jack Krasuski, MD |
Depressive Disorders |
Major Depressive Disorder – Adrian Preda, MD |
Depression During Pregnancy – Jennifer L. Payne, MD |
Depression in the Medically Ill – Jeff Huffman, MD |
Premenstrual Dysphoric Disorder – Karen G. Martinez-Gonzalez, MD |
Anxiety Disorders |
Separation Anxiety Disorder – Karen G. Martinez-Gonzalez, MD |
Selective Mutism – Jack Krasuski, MD |
Social Anxiety Disorder (Social Phobia) – Jack Krasuski, MD |
Panic Disorder and Panic Attack – Jack Krasuski, MD |
Agoraphobia – Jack Krasuski, MD |
Generalized Anxiety Disorder – Jack Krasuski, MD |
Perinatal Anxiety – Jennifer L. Payne, MD |
Pediatric Anxiety Disorders – Molly McVoy, MD |
Obsessive-compulsive Disorders |
Body Dysmorphic Disorder – Jack Krasuski, MD |
Hoarding Disorder – Catherine R. Ayers, PhD |
Trichotillomania and Excoriation Disorders – Karen G. Martinez-Gonzalez, MD |
Trauma and Stressor Disorders |
Reactive Attachment Disorder and Disinhibited Social Engagement Disorder – Damion J. Grasso, PhD |
Acute Stress Disorder – Jack Krasuski, MD |
Adjustment Disorder – Jean Kim, MD |
Prolonged Grief Disorder – Damion J. Grasso, PhD |
Psychotherapeutic Treatments |
Pediatric PTSD Psychotherapeutic Treatments – Damion J. Grasso, PhD |
Dissociative Disorders |
Dissociative Identity Disorder – Jack Krasuski, MD |
Dissociative Amnesia – Jack Krasuski, MD |
Depersonalization/Derealization Disorder – Jack Krasuski, MD |
Somatic Symptom and Related Disorders |
Somatic Symptom Disorder – Jean Kim, MD |
Illness Anxiety Disorder – Jaroslava Salman, MD |
Conversion Disorder – David Bienenfeld, MD |
Factitious Disorder – Jack Krasuski, MD |
Eating, Feeding, and Elimination Disorders |
Bulimia Nervosa – Ellen Fitzsimmons-Craft, PhD |
Binge Eating Disorder – Claire Wilcox, MD |
Cognitive Behavioral Therapy for Eating Disorders – Ellen Fitzsimmons-Craft, PhD |
Pica, Rumination Disorder, and Avoidant Restrictive Food Intake Disorder – Claire Wilcox, MD |
Enuresis and Encopresis – Karen G. Martinez-Gonzalez, MD |
Sleep-Wake Disorders |
Hypnotic Z Drugs – Angela L. Goodhart, PharmD |
Hypersomnolence Disorder – Jack Krasuski, MD |
Narcolepsy – Jack Krasuski, MD |
Central Sleep Apnea – Jack Krasuski, MD |
Circadian Rhythm Sleep-Wake Disorders – Jack Krasuski, MD |
Non-REM Sleep Arousal Disorder – Jack Krasuski, MD |
Nightmare Disorder – Jack Krasuski, MD |
Substance/Medication – Induced Sleep Disorders – Jack Krasuski, MD |
Sleep Disorders in Aging – David Bienenfeld, MD |
Disruptive, Impulse-control, and Conduct Disorders |
Oppositional Defiant Disorder and Conduct Disorder – Jack Krasuski, MD |
Pyromania – Jack Krasuski, MD |
Kleptomania – Jack Krasuski, MD |
Substance-Related and Addictive Disorders |
Alcohol Use Disorders – Jack Krasuski, MD |
Caffeine Intoxication and Caffeine Withdrawal – Jack Krasuski, MD |
Strategies to Help Patients and Families Affected by Cannabis Use or Cannabis Use Disorder |
Hallucinogen Use Disorder – Jack Krasuski, MD |
Kratom – Corneliu N. Stanciu, MD |
Inhalant Use Disorder and Intoxication – David A. Gorelick, MD |
Opioid Use Disorder – Jack Krasuski, MD |
Suboxone Initiation & Management – Gregory Nikogosyan, DO |
Benzodiazepine Use Disorders: Update on Management – Induced Sleep Disorders – David A. Gorelick, MD |
Sedative, Hypnotic, or Anxiolytic Use Disorder – Jack Krasuski, MD |
Tobacco Use Disorder – Jack Krasuski, MD |
Behavioral Addictions – Amanda K. Janner, Psy.D |
Neurocognitive Disorders |
Delirium – Jack Krasuski, MD |
Alzheimer’s Disease – Marc E. Agronin, MD |
Lewy Body Dementias – Brooke Dulka, PhD |
Traumatic Brain Injury and Psychiatric Disorders – Joanne A. Byars, MD |
Neurocognitive Disorder Due to Prion Disease – Jack Krasuski, MD |
Neurocognitive Disorder Due to Huntington’s Disease – Jack Krasuski, MD |
Do Commonly Used Medications Cause Dementia? – Joanne A. Byars, MD |
Personality Disorders |
Paranoid Personality Disorder – Jack Krasuski, MD |
Borderline Personality Disorder – Jack Krasuski, MD |
Dark Triad Traits – Jack Krasuski, MD |
Sexual Dysfunctions & Paraphilic Disorders |
Sexual Dysfunctions – Jack Krasuski, MD |
Substance/Medication-Induced Sexual Dysfunction – Michael W. Jann, PharmD |
Neuromodulation and Related Treatments |
Neuromodulation in Mental Health Disorders – Jack Krasuski, MD |
Transcranial Magnetic Stimulation – Sandeep Vaishnavi, MD |
Electroconvulsive Therapy – Jack Krasuski, MD |
Bright Light Therapy – Michael W. Jann, PharmD |
Psychopharmacologic Treatments |
Antidepressants: Pharmacogenomic Applications – Michael W. Jann, PharmD |
Psychedelics, Ketamine, Esketamine Treatment for Depression and PTSD – David A. Gorelick, MD |
Lithium During Pregnancy and Delivery – Gregory Nikogosyan, DO |
Brexanolone and Zuranolone – Jack Krasuski, MD |
Dextromethorphan/Bupropion for Depression – Adrian Preda, MD |
Antipsychotics – Joseph McEvoy, MD |
Aducanumab – Jack Krasuski, MD |
Mood Stabilizers: Pharmacogenomic Applications – Michael W. Jann, PharmD |
Stimulants – David A. Gorelick, MD |
Weaning Patients from Long-Term Benzodiazepine Use – Claire Wilcox, MD |
Psychotropic Drugs and Cardiovascular Risks – Shaun Kink, MD |
Psychedelic Medicine – Thaddeus Camlin, PsyD |
Psychotherapeutic Treatments |
Acceptance and Commitment Therapy – Jack Krasuski, MD |
Clinical Use of Dreams in Therapy – Selen Atasoy, PhD |
Mindfulness-based Therapies – Stephen Ilardi, PhD and Haley Hart |
Psychosocial Rehab / Day programs – Blaire Ehret, PhD |
Miscellaneous Topics |
Risk Management – Kevin Kinback, MD |
Pain for the Non-Specialist – Jack Krasuski, MD |
Pain for the Non-Specialist: Managing Chronic Pain – Jack Krasuski, MD |
Mental Health Consequences and the COVID-19 Pandemic – Jack Krasuski, MD |
Adverse Childhood Experiences – Damion J. Grasso, PhD |
Medication Adherence – Martha Sajatovic, MD |
The Psychological and Psychiatric Issues Related to Life Phases – Daniel R. Hanson, MD |
Clinical Reasoning in Psychiatry – Descartes Li, MD & Kewchang Lee, MD |
Gut Biome and its Role in Psychiatric Disorders – Jack Krasuski, MD |
Nutrition and Mental Health: An Introduction – Jack Krasuski, MD |
Nutrition and Mental Health: Eating and Feeding Disorders – Jack Krasuski, MD |
Non-Clinical Careers for Physicians – Jack Krasuski, MD |
Negotiation Strategies for Physicians – Jack Krasuski, MD |
Suicide Management Evidence-Based Treatments – Blaire Ehret, PhD |
Weight Gain, Obesity, and Metabolic Syndrome in Psychiatry – Claire Wilcox MD |
Interviews |
Interview with Dr. Jack Krasuski and Dr. Claire Wilcox |
Interview with Dr. Jack Krasuski and Dr. Nassir Ghaemi |
Interview with Dr. Jack Krasuski and Dr. William Miller |
Interview with Dr. Jack Krasuski and Dr. Thomas Lynch |
Interview with Dr. Jack Krasuski and Dr. Charles Fernyhough |
Interview with Dr. Jack Krasuski and Dr. Paul Wachtel |
Meet Our Expert Faculty Members
What Physicians Report About CMEtoGO!
CMEtoGO is a comprehensive, engaging, and very convenient way of keeping up with ABPN MOC requirements! I highly recommend it!
I’m a wife and mom of small kids who works 80 miles from home. So like many early career psychiatrists I have a dearth of time. Therefore CMEtoGO has been a huge blessing in meeting my CME requirements.
CMEtoGO is outstanding and provides the most clinically useful information available in an outstanding format.
Easiest means of getting up-to-date and reliable data, presenting the most relevant facts objectively. Builds your knowledge base so you can more easily quote and recall the salient facts in your clinical practice or in support of your research.
Time and money spent well. Are you scared of MOC? No need to be anymore with CMEtoGO.
I endorse this product wholeheartedly. Very satisfied. Would strongly recommend my colleagues to subscribe.
CMEtoGO is the best CME program I found so far for ongoing growth in my psychiatric knowledge.
The incorporation of ease of use with the comprehensive nature of the topics is the best of both worlds! Thanks!
Awesome lectures, simple, easy format without confusing research jargon.
I live in the city and walk everywhere. I am so happy I can use that time to get my CME. The lectures presented by CMEtoGO are interesting and applicable to my practice. I am extremely pleased!
CMEtoGO is ‘continuing medical education made easy and without tears.
Very convenient and very good. What you would expect from API.
Very user-friendly. Easily accessed. Very informative.
CMEtoGO is excellent for professionals like me who drive 45-60 minutes to get to work, who are mothers and for whom time is a luxury. You keep me updated of clinically- relevant topics and meet the requirements for my license renewal and MOC. Thanks!
I am very pleased with this service so far. The quality is excellent and surpasses other online CME products I’ve used.
I recommend CMEtoGO. It keeps me up-to-date, is time efficient, and meets my board requirements.
Easy-to-use format, good coverage of most topics in psychiatry.
Well worth the time and money. You have the option of reading the lectures or listening to them, which is very convenient. Additionally, the ease of testing and retrieval of CME is favorable.
The content of the lectures is very good, as is the ease of use.
It’s a great way to review topics that you need to stay up-to-date on, and to be exposed to topics you weren’t actually aware you needed to know!
Very useful, to the point, saves time.
CME Accreditation
Intended Audience: Psychiatrists
Accreditation Statement:
CMEtoGO Psychiatry has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of PeerPoint Medical Education Institute and The American Physician Institute for Advanced Professional Studies, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to sponsor continuing medical education for physicians.
The American Board of Psychiatry and Neurology has reviewed CMEtoGO Psychiatry and has approved this program as a part of a comprehensive Self-Assessment Program, which is mandated by the ABMS as a necessary component of Maintenance of Certification.
CMEtoGO Psychiatry Designation Statement:
Online Course, Release Date January 1, 2025, Termination Date December 31, 2027:
The PeerPoint Medical Education Institute, LLC designates this enduring material activity for a maximum of 126 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Of these 126 credits: 24 also qualify as ABPN Self Assessment credits.